loadpatents
name:-0.047569036483765
name:-0.045835971832275
name:-0.0060901641845703
UNIVERSITE D'AUVERGNE Patent Filings

UNIVERSITE D'AUVERGNE

Patent Applications and Registrations

Patent applications and USPTO patent grants for UNIVERSITE D'AUVERGNE.The latest application filed is for "orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating e. coli induced ".

Company Profile
5.12.11
  • UNIVERSITE D'AUVERGNE - Clermont-Ferrand N/A FR
  • UNIVERSITE D'AUVERGNE - Clermont-Ferrand Cedex FR
  • UNIVERSITE D'AUVERGNE - Villeneuve d'Ascq N/A FR
  • UNIVERSITE D'AUVERGNE - Clemont-Ferrand FR
  • UNIVERSITE D'AUVERGNE - Clemont-Ferrand Cedex 1 FR
  • UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND CEDEX 1 FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Lipophenol compounds and uses thereof
Grant 11,014,947 - Brabet , et al. May 25, 2
2021-05-25
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
Grant 10,632,135 - Bouckaert , et al.
2020-04-28
Orally Available Compounds, A Process For Preparing The Same And Their Uses As Anti-adhesive Drugs For Treating E. Coli Induced
App 20190374559 - BOUCKAERT; Julie ;   et al.
2019-12-12
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
Grant 10,485,811 - Bouckaert , et al. Nov
2019-11-26
Multimeric mannosides, a process for preparing the same and their uses as a drug
Grant 10,273,313 - Bouckaert , et al.
2019-04-30
New Lipophenol Compounds And Uses Thereof
App 20180273554 - BRABET; Philippe ;   et al.
2018-09-27
Lipophenol compounds and uses thereof
Grant 10,011,620 - Brabet , et al. July 3, 2
2018-07-03
Centrally Acting Acetylcholinesterase Inhibitors For The Prevention And/or Treatment Of Chemically Induced Neuropathies And The Symptoms Thereof, And Corresponding Compositions, Uses, Methods And Kit
App 20180085360 - ESCHALIER; ALAIN ;   et al.
2018-03-29
Centrally Acting Acetylcholinesterase Inhibitors For The Prevention And/or Treatment Of Chemically Induced Neuropathies And The Symptoms Thereof, And Corresponding Compositions, Uses, Methods And Kit
App 20170128428 - ESCHALIER; ALAIN ;   et al.
2017-05-11
New Lipophenol Compounds And Uses Thereof
App 20170037067 - BRABET; Philippe ;   et al.
2017-02-09
Orally Available Compounds, A Process For Preparing The Same And Their Uses As Anti-adhesive Drugs For Treating E. Coli Induced Inflammatory Bowel Diseases Such As Crohn's Disease
App 20160340445 - BOUCKAERT; Julie ;   et al.
2016-11-24
Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof
Grant 9,212,196 - Acher , et al. December 15, 2
2015-12-15
Multimeric Mannosides, A Process For Preparing The Same And Their Uses As A Drug
App 20150210781 - Bouckaert; Julie ;   et al.
2015-07-30
Method For Performing Homologous Recombination
App 20150189844 - Paul; Wyatt ;   et al.
2015-07-09
Composition for the Prophylactic Treatment of Neuropathic Pain
App 20140378551 - Pickering; Gisele
2014-12-25
Method and equipment for analyzing biological signals representing intracranial and blood pressure fluctuations
Grant 7,160,250 - Lemaire January 9, 2
2007-01-09
Method for detecting microorganisms
App 20050130169 - Romond, Pierre-Charles ;   et al.
2005-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed